Reach Us +1-947-333-4405


Editor - Dennis O Adeegbe | Osaka University | 15000
ISSN: 2332-0877

Journal of Infectious Diseases & Therapy
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Google scholar citation report
Citations : 1224

Journal of Infectious Diseases & Therapy received 1224 citations as per google scholar report

Indexed In
  • Index Copernicus
  • Google Scholar
  • Open J Gate
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • Publons
  • Euro Pub
Share This Page

Dennis O Adeegbe

Dennis O Adeegbe
Dennis O Adeegbe
Lab of Experimental Immunology
Immunology Frontier Research Center
Osaka University
Osaka University


 Dr. Adeegbe received his bachelors degree at Florida A&M University. He completed his graduate education in the department of Microbiology & Immunology at the Miller School of Medicine, University of Miami, where he obtained his PhD. In continuation of his research interests in autoimmunity and transplantation tolerance, he joined the Diabetes Research Institute Foundation, an affiliate research center within the medical school as a postdoctoral fellow where he focused on cellular mechanisms to promote tolerance to allografts. He continued his postdoctoral fellowship in the lab of world-renowned immunologist, Shimon Sakaguchi (Japan) where he is currently finishing his fellowship in preparation for a scientific career in the field of autoimmunity, transplantation tolerance, and tumor immunobiology. His current research revolves around elucidating the mechanisms of Treg cell-mediated tolerance both in the context of self and tumor-associated antigens, the latter being important for designing effective therapeutic modalities to augment anti-tumor immunity.


Research Interest

 Autoimmunity, transplantation, cancer immunity.



Global Speakers in the subject

Global Experts in the subject